Recommendations

 

Recommendations (Gabriel Giovene)

For Eli Lilly, I feel that one of the most important parts of being a business that Eli Lilly needs to start stepping into is the marketing landscape. We never really see a social media presence and also not much advertising for them. This all is an important part of being a business, and while researching them it shows that they neglect that aspect of the business. When monitoring their social media, you can see how underutilized it is with some posts going all the way back years ago. Some of their posts also consist of information that is not really relevant to what their business model is. Recommendations for improving this are staying more focused on the posts that you are tweeting/posting, make sure that it is informative and grabs the consumers attention. Need for engagement in social media platforms, what I mean by that is to have some posts that can get the readers involved, have people coming back to see what the news is and what advances you have made. Last, stay active on your platforms, make sure that you are posting at a steady pace, you can not go over a year without a post, it drops engagement.

Eli Lilly needs a better customer support system, when going through customer questions or complaints, it is clear that they are using an automated system to respond to these questions. That needs to be addressed because when it comes to a text file that is just being sent out every time someone has a concern, it comes off to the customer that they do not want to be helped. With advances in technology, AI may become a huge aspect that Eli Lilly should start to look into. With that aspect added to the customer support system, you can have the AI address the issues that could be from fulfillments or issues on payments, and then anything that can not be addressed by them can be pushed to a human. What this does at least for Eli Lilly is give the customer engagement that does not make them feel like they are talking to a sentence that was automated on their comment.

When we look at how their supply chain management works, some recommendations they could use is more AI when it comes to doing orders or even looking over what they can improve on. With AI becoming such a big important part of the businesses these days, it would be wise for Eli Lilly to start to look into this, so that they can keep up with their competitors. They can do so much with AI, this could include going over the analytics and also what their medications success rates can be in the long run. The future of business is going to be relying more and more on how AI can be integrated so that its success rate works and how fast they can get data back to the scientists who may be going over the analytics.

Recommendations (Daysi Valido)

Eli Lilly & Company is a renowned pharmaceutical corporation known for its innovative medicines and healthcare solutions. To further improve its standing and continue its positive impact, several recommendations can be considered. Firstly, investing more resources in research and development could bolster the company's pipeline of novel drugs and therapies. By prioritizing innovative research and collaborations, Eli Lilly can expand its portfolio and address unmet medical needs in various therapeutic areas. Secondly, focusing on sustainability initiatives, such as reducing environmental impact and promoting ethical practices throughout its supply chain, would align the company with evolving societal expectations and contribute to long-term growth. Thirdly, emphasizing digital health solutions and leveraging advanced technologies like AI and data analytics can enhance patient care, drug development processes, and overall operational efficiency. Lastly, fostering a culture of diversity, equity, and inclusion within the company would not only attract top talent but also ensure a broad perspective in decision-making, leading to more comprehensive solutions for global healthcare challenges. Continuously adapting to evolving market dynamics while maintaining a commitment to scientific excellence and social responsibility will likely strengthen Eli Lilly & Company's position in the pharmaceutical industry.